E
Cogent Biosciences, Inc. COGT
$12.23 $0.443.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 25.85% 23.35% 25.91% 28.97% 32.26%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.51% 26.91% 32.58% 34.49% 43.13%
Operating Income -22.51% -26.91% -32.58% -34.49% -43.13%
Income Before Tax -25.12% -27.02% -32.98% -36.38% -44.30%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -25.12% -27.02% -32.98% -36.38% -44.30%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -25.12% -27.02% -32.98% -36.38% -44.30%
EBIT -22.51% -26.91% -32.58% -34.49% -43.13%
EBITDA -22.67% -27.13% -32.85% -34.69% -43.22%
EPS Basic 99.65% 99.66% -29,898.61% -30,730.15% -32,674.43%
Normalized Basic EPS 99.66% 99.66% -30,022.50% -30,815.87% -32,770.16%
EPS Diluted 99.65% 99.66% -29,898.61% -30,730.15% -32,674.43%
Normalized Diluted EPS 99.66% 99.66% -30,022.50% -30,815.87% -32,770.16%
Average Basic Shares Outstanding 65.14% 75.29% 0.80% -1.96% -4.67%
Average Diluted Shares Outstanding 65.14% 75.29% 0.80% -1.96% -4.67%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --